FDA, Mylan silence on generic Advair may be good news for GSK
Signage for GlaxoSmithKline is seen on it’s offices in London, Britain, March 30, 2016. REUTERS/Toby Melville/File Photo A deadline for U.S. regulators to give a verdict on a generic copy of GlaxoSmithKline’s blockbuster inhaled lung drug Advair has passed wit... More »
